Join the 200th Anniversary Celebration

Original Article

A Comparison of Continuous Thalamic Stimulation and Thalamotomy for Suppression of Severe Tremor

P. Richard Schuurman, M.D., D. Andries Bosch, M.D., Ph.D., Patrick M.M. Bossuyt, Ph.D., Gouke J. Bonsel, M.D., Ph.D., Eus J.W. van Someren, Ph.D., Rob M.A. de Bie, M.D., Maruschka P. Merkus, Ph.D., and Johannes D. Speelman, M.D., Ph.D.

N Engl J Med 2000; 342:461-468February 17, 2000

Abstract

Background

Deep-brain stimulation through an electrode implanted in the thalamus was developed as an alternative to thalamotomy for the treatment of drug-resistant tremor. Stimulation is thought to be as effective as thalamotomy but to have fewer complications. We examined the effects of these two procedures on the functional abilities of patients with drug-resistant tremor due to Parkinson's disease, essential tremor, or multiple sclerosis.

Methods

Sixty-eight patients (45 with Parkinson's disease, 13 with essential tremor, and 10 with multiple sclerosis) were randomly assigned to undergo thalamotomy or thalamic stimulation. The primary outcome measure was the change in functional abilities six months after surgery, as measured by the Frenchay Activities Index. Scores for this index can range from 0 to 60, with higher scores indicating better function. Secondary outcome measures were the severity of tremor, the number of adverse effects, and patients' assessment of the outcome.

Results

Functional status improved more in the thalamic-stimulation group than in the thalamotomy group, as indicated by increases in the score for the Frenchay Activities Index (from 31.4 to 36.3 and from 32.0 to 32.5, respectively; difference between groups, 4.4 points; 95 percent confidence interval, 2.0 to 6.9). After adjustment for base-line characteristics, multivariate analysis also showed that the thalamic-stimulation group had greater improvement (difference between groups, 5.1 points; 95 percent confidence interval, 2.3 to 7.9). Tremor was suppressed completely or almost completely in 27 of 34 patients in the thalamotomy group and in 30 of 33 patients in the thalamic-stimulation group. One patient in the thalamic-stimulation group died perioperatively after an intracerebral hemorrhage. With the exception of this incident, thalamic stimulation was associated with significantly fewer adverse effects than thalamotomy. Functional status was reported as improved by 8 patients in the thalamotomy group, as compared with 18 patients in the thalamic-stimulation group (P=0.01).

Conclusions

Thalamic stimulation and thalamotomy are equally effective for the suppression of drug-resistant tremor, but thalamic stimulation has fewer adverse effects and results in a greater improvement in function.

Media in This Article

Figure 1Scores on the Frenchay Activities Index at Base Line and at the Six-Month Follow-up Visit, According to Treatment.
Table 1Base-Line Characteristics of the Patients.
Article

Tremor can be an incapacitating symptom that leads to functional impairment. In patients with Parkinson's disease and in those with essential tremor, pharmacologic treatment often does not adequately control tremor. In patients with multiple sclerosis, intention tremor can add considerably to their disability.

Neurosurgical thalamotomy is effective in 73 to 93 percent of patients with incapacitating tremor that is refractory to drug therapy.1-6 However, this procedure is accompanied by permanent complications in 9 to 23 percent of patients with Parkinson's disease or essential tremor1,2,5-8 and in 16 to 41 percent of patients with multiple sclerosis.7,9,10 Bilateral thalamotomy carries an even higher risk11-13 and is no longer recommended.14

Continuous deep-brain stimulation through an electrode implanted in the thalamus is an alternative to ablative surgery.15 Thalamic stimulation has been adopted by many centers, and clinical studies suggest that this approach is as effective as thalamotomy and has fewer complications, allowing bilateral treatment.14-24

To test the hypothesis that thalamic stimulation produces greater functional improvement than thalamotomy because of its lower rate of complications, we conducted a randomized comparison of thalamic stimulation and thalamotomy in patients with unilateral or bilateral tremor due to Parkinson's disease, essential tremor, or multiple sclerosis.

Methods

Patients

Eligible patients had had severe unilateral or bilateral tremor of the arms due to Parkinson's disease, essential tremor, or multiple sclerosis for at least one year despite pharmacotherapy. The severity of tremor was defined with the use of disease-specific clinical scales: the tremor item of the Unified Parkinson's Disease Rating Scale25 in the case of patients with Parkinson's disease, the Essential Tremor Rating Scale26 in the case of patients with essential tremor, and the Modified Tremor Scale27 in the case of patients with multiple sclerosis. Patients were not eligible for the study if they were younger than 18 years of age; had cognitive dysfunction, as defined by a score of less than 24 on the Mini–Mental State Examination28; had contraindications to surgery (unstable cardiac or pulmonary disease or coagulation disorders); had evidence of advanced cerebral atrophy on computed tomographic scans; or had previously undergone thalamotomy. At base line, the stage of disease was assessed with the Hoehn and Yahr29 staging system and the Unified Parkinson's Disease Rating Scale in patients with Parkinson's disease (range of activity subscores, 0 to 52; range of motor subscores, 0 to 108), the Essential Tremor Rating Scale in patients with essential tremor (range of scores, 0 to 144), and the Kurtzke Expanded Disability Status Scale30 in patients with multiple sclerosis (range of scores, 0 to 10). For all three scales, lower scores indicate better function. All patients provided written informed consent, and the study was approved by the medical ethics committee of the hospital. Randomization was performed according to a computer-generated code, with adjustment for the cause and extent of tremor (unilateral vs. bilateral).

Surgical Treatment

Within one month after randomization, patients underwent surgery under local anesthesia. Patients with unilateral tremor either had an electrode implanted or underwent unilateral thalamotomy. Patients with bilateral tremor either had bilateral implantation of electrodes in one session or underwent unilateral thalamotomy directed at the hand with the most severe tremor, followed six months later by contralateral implantation of an electrode.

The position of the nucleus ventralis intermedius thalami relative to the intercommissural line was identified by positive contrast ventriculography, according to the stereotactic atlas of Schaltenbrand and Wahren.31 Intraoperatively, we applied macroelectrodes to identify the optimal position for the lesion or the electrode; the same position was used for both. The site selected was the one in which the effect of the lowest-threshold high-frequency stimulation (130 Hz) was maximal and in which neither high-frequency stimulation nor low-frequency stimulation (2 Hz) produced side effects. We did not use microelectrode recordings. Once the site was selected, either a lesion was produced by applying the bare tip of a 1.5-by-3.8-mm macroelectrode at a temperature of 80°C for 60 seconds, or a four-contact electrode (model 3387DBS, Medtronic, Minneapolis) was implanted, with the second distal contact placed at the target site. After several days of testing, the electrodes were connected to an implantable pulse generator (Itrell II, Medtronic) with the patient under general anesthesia. The surgical technique was not changed during the course of the study.

Outcome Measures

The patients were assessed preoperatively and at three-month intervals for two years after surgery. The results of thalamotomy six months after surgery have been shown to be predictive of its long-term effect,13,32 and these outcomes were used for the main analyses. The primary outcome measure was the change from base line in functional status, as measured by the Frenchay Activities Index,33 for which a validated Dutch version is available.34 This index assesses 15 activities of daily life involving domestic tasks (preparing meals, washing up, washing clothes, doing light housework, and doing heavy housework), leisure or work-related activities (attending social events, pursuing hobbies, going on outings, performing household or car maintenance, reading, and working), and other or outdoor activities (shopping, walking, traveling, and gardening). The items are measured on a four-point scale, and scores can range from 0 to 60. An increase of four points in the score indicates an improvement in the patient's ability to perform at least two of these activities. In earlier research an increase of five points was associated with a clinically relevant improvement in the ability to perform the activities of daily life.34 We used the Frenchay Activities Index rather than disease-specific scales of functional status because this instrument could be used for the entire study population.

Secondary outcome measures were tremor of the arm, adverse effects (including changes in cognitive status), and the patient's opinion of the surgical outcome. Tremor was assessed from videotaped recordings made at base line and six months after surgery (with patients wearing surgical caps to conceal changes in hairstyle after surgery) according to the items on tremor in the Unified Parkinson's Disease Rating Scale, Essential Tremor Rating Scale, and Modified Tremor Scale. The videotapes were played in random order and analyzed by an independent neurologist who was unaware of the patient's condition or treatment. Videotapes were made of the patients during drug therapy and during thalamic stimulation in patients who received electrodes. A list of possible complications was devised and used to record adverse effects at each follow-up assessment, after a full neurologic examination. Cognitive status was assessed by neuropsychological evaluation both preoperatively and at six months. The patients were asked to rate the change in their ability to perform complex activities using a nine-point ordinal scale in which a score of 0 indicated that their ability to function was “much worse” and a score of 8 that it was “much better.”

Statistical Analysis

The difference in the changes in the Frenchay Activities Index score from base line to six months after surgery between the treatment groups was analyzed with Student's t-test. In addition, we performed a conditional, multivariable analysis, using general linear modeling and adjusting for the base-line variables of age, sex, diagnosis, duration of disease, extent of tremor (unilateral vs. bilateral), severity of disease, and base-line Frenchay Activities Index scores. For this purpose, severity of disease was calculated as the patient's score divided by the maximal score on the disease-specific clinical scales.

The change in the tremor score from base line to the six-month follow-up visit was compared with use of Mann–Whitney U tests. In patients with bilateral stimulation, only the score of the hand with the more severe tremor was used in the primary analysis, since this was the hand targeted in the patients who had undergone thalamotomy. The proportions of patients with complications in each group were compared with use of a chi-square test. The difference between groups in the patients' assessment of functional status at six months was also analyzed with the use of Mann–Whitney U tests. Subgroup analyses were performed according to the cause and extent of tremor. The analyses were performed on an intention-to-treat basis. Two-sided P values of less than 0.05 were considered to indicate statistically significant differences.

Assuming a standard deviation of 7 points, an alpha level of 0.05, and a beta level of 0.20, we estimated that 32 patients would be needed in each treatment group for the study to have the power to detect a 5-point difference in scores on the Frenchay Activities Index. A target of 70 patients was set.

Results

Characteristics of the Patients

Between June 1995 and October 1998, 175 patients were referred by neurologists throughout the Netherlands. Of these patients, 105 were excluded for the following reasons: further pharmacologic options were available (28 patients), there was evidence of cognitive deterioration (8) or surgical contraindications (22), parkinsonism was part of multiple-system atrophy (4), mild tremor did not interfere with normal physical or social functioning (20), there was an indication for pallidal rather than thalamic surgery (19), the patient had previously undergone thalamotomy (1), and the patient declined to participate (3). The remaining 70 patients underwent randomization. Two patients were not treated: one withdrew after contracting an unrelated disease, and the other was judged to be a more suitable candidate for pallidal surgery after prolonged clinical observation.

Two patients with Parkinson's disease and bilateral tremor who were randomly assigned to thalamic stimulation died before follow-up was complete. One died of complications after implantation of the test electrode. A small intracerebral hematoma caused decreased consciousness and was followed by aspiration pneumonia and, ultimately, by respiratory failure. Since postoperative values could not be assessed, this patient was assigned the lowest score of the study population on the primary outcome measure at follow-up. The other patient had no complications postoperatively or at the three-month follow-up visit but died of a myocardial infarction five months after surgery. This patient's values for the three-month follow-up assessment were carried forward for the analyses. Data on 68 patients were thus available for analysis.

Table 1Table 1Base-Line Characteristics of the Patients. lists the base-line characteristics of the patients. The thalamic-stimulation group had significantly more men than women. Among the patients with Parkinson's disease, the motor-function score for the Unified Parkinson's Disease Rating Scale (part III) was significantly higher in the thalamic-stimulation group; this difference was attributable to differences in overall rigidity and agility of the leg.

Scores for the Frenchay Activities Index

Patients with unilateral tremor had higher Frenchay Activities Index scores at base line than patients with bilateral tremor (Table 1). The average base-line scores were similar in patients with Parkinson's disease and in those with essential tremor and lowest in those with multiple sclerosis. The mean score in the thalamic-stimulation group increased from 31.4 at base line to 36.3 at six months. The mean score in the thalamotomy group increased from 32.0 to 32.5. In Figure 1Figure 1Scores on the Frenchay Activities Index at Base Line and at the Six-Month Follow-up Visit, According to Treatment., the individual scores for the Frenchay Activities Index at the six-month follow-up visit are plotted against base-line scores.

Table 2Table 2Changes in the Scores for the Frenchay Activities Index from Base Line to the Six-Month Follow-up Visit. shows the changes in the scores for the Frenchay Activities Index from base line to the six-month follow-up visit for all patients as well as for the various subgroups. There was a significant difference of 4.4 points (95 percent confidence interval, 2.0 to 6.9) in the extent of improvement after surgery between the thalamotomy group and the thalamic-stimulation group, with greater improvement in the latter group. Thalamic stimulation also resulted in greater improvement than did thalamotomy in patients with bilateral tremor, those with unilateral tremor, those with Parkinson's disease, and those with essential tremor, but not in patients with multiple sclerosis.

The results of multivariate analysis, after adjustment for the base-line characteristics of age, sex, cause of the tremor, severity of disease, and scores on the Frenchay Activities Index, were similar to those of the unconditional univariate analysis. Patients assigned to receive thalamic stimulation had greater improvements in scores than patients assigned to undergo thalamotomy (a difference between groups of 5.1 points; 95 percent confidence interval, 2.3 to 7.9).

Tremor

Tremor grades at base line and at the six-month follow-up visit are listed in Table 3Table 3Severity of Tremor at Base Line and at the Six-Month Follow-up Visit.. There was no significant difference between the two groups at base line or at the six-month follow-up visit. Total suppression of tremor (grade 0) or almost complete suppression (grade 1, defined as occasional, slight tremor) was achieved in 27 of 34 patients in the thalamotomy group and in 30 of 33 patients in the thalamic-stimulation group. Data on tremor were not available for the patient with Parkinson's disease who died of complications of electrode implantation. Treatment reduced or eliminated tremor more successfully in patients with Parkinson's disease and in patients with essential tremor than in those with multiple sclerosis. Directly after thalamotomy, tremor disappeared in all patients, but at six months six patients had mild tremor and one had moderate tremor. Tremor also disappeared in all patients immediately after thalamic stimulation, but at six months one patient had mild tremor and two had moderate tremor.

Adverse Effects

Table 4Table 4Incidence of Adverse Effects Immediately after Surgery and at the Six-Month Follow-up Visit. lists the adverse effects that were reported immediately after surgery and at the six-month follow-up visit. Six months after surgery, 16 patients in the thalamotomy group had adverse effects, as did 6 of the patients in the thalamic-stimulation group (P= 0.024). The adverse effects in the thalamic-stimulation group at the six-month follow-up visit disappeared once the pulse generators were switched off. Three patients in the thalamotomy group had cognitive deterioration, which was confirmed by neuropsychological testing: one had loss of initiative, one had decreased memory, and one had decreased language fluency. In the thalamic-stimulation group, there were two equipment-related complications: one patient had a hematoma near the pulse generator, and in one the pulse generator became infected and was replaced after antibiotic treatment.

Patients' Assessments of Treatment

After thalamotomy, 8 patients judged their functional status to have improved, 22 patients reported no change in overall functional status, and 4 patients reported that their condition had deteriorated. In the thalamic-stimulation group, 18 patients judged their functional status to have improved, 13 thought that it was unchanged, and 2 thought that it was worse. The results differed significantly between the two groups (P=0.01).

Discussion

Our randomized comparison of deep-brain stimulation and thalamotomy is of one of the few studies that have focused on functional status as a primary outcome measure rather than symptoms of disease.35 Thalamic stimulation resulted in greater improvement in function than thalamotomy, according to both objective and subjective measures. Thalamic stimulation and thalamotomy were equally effective in reducing drug-resistant tremor, whereas stimulation had fewer adverse effects, although one patient in this group died perioperatively.

Patients were aware of which treatment they received, and information provided in the informed-consent form may have led to expectation bias, influencing patients' assessment of the outcome and their responses to questions on the Frenchay Activities Index. The fact that patients in the thalamic-stimulation group required more frequent medical contact for adjustment of the equipment may also have confounded the results. The clinical investigators were also aware of the treatment the patients received, which may have caused surveillance bias with respect to the identification of adverse effects. The assessment of tremor was performed in a single-blind fashion, since the neurologist who reviewed the videotapes was unaware of the patient's treatment assignment and treatment status. Patients were unaware that the Frenchay Activities Index questionnaire was used as the primary outcome measure, since completing the questionnaire took up only a small part of each evaluation.

Patients in the thalamic-stimulation group had a clinically relevant improvement in their ability to perform the activities of daily life. No such overall improvement was evident in the thalamotomy group, on the basis of either the scores on the Frenchay Activities Index or the patients' assessments. It is conceivable that the adverse functional effects of thalamotomy were underestimated in previous studies because the resulting complications were not assessed. There was a disappointing overall improvement in function after unilateral reduction of tremor with thalamotomy in patients with bilateral tremor.

Our data compare well with the results of other studies that assessed the ability of thalamic stimulation to suppress tremor. In other reports the efficacy ranged from 71 to 94 percent in patients with Parkinson's disease and from 68 to 89 percent in patients with essential tremor.14,15,18,23,36,37 Our results for thalamotomy are also similar to those of other studies.1-6

Thalamic stimulation was effective in 70 percent of patients with multiple sclerosis in two small series,19,23 but the preliminary results of a prospective evaluation were less favorable.38 Thalamotomy has been reported to result in long-term suppression of tremor in 30 percent39 to 80 percent40 of patients with multiple sclerosis, and this wide range probably relates to the varied origins of tremor, which depend on the location of the sclerotic lesions.17 In our study, the response to surgery of patients with multiple sclerosis was not as good as that of patients with Parkinson's disease or essential tremor. In patients with multiple sclerosis, tremor was less likely to be suppressed, and the unmasking of cerebellar dysmetria might have limited functional gain. Stereotactic treatment of tremor in patients with multiple sclerosis should probably be restricted to patients with stable disease whose tremor does not have a severe ataxic component and who have few other deficits.

Although one patient died perioperatively in the thalamic-stimulation group, there was a significant difference in the incidence of adverse effects between this group and the thalamotomy group. Sixteen of the patients in the thalamotomy group had complications at the six-month follow-up visit. This rate is higher than the rates in most published series; for example, the rate of permanent complications ranged from 9 to 23 percent in patients with Parkinson's disease,1,6 13 to 38 percent in patients with essential tremor,5,8 and 16 to 41 percent in patients with multiple sclerosis.7,9 However, surgical studies that included prospective collection of data reported considerably higher rates of adverse events than retrospective studies.41,42

In our study, the use of microelectrode recordings to identify the optimal location for the intervention may have reduced morbidity, although this issue is still controversial. Six of 33 patients in the thalamic-stimulation group had side effects only while the pulse generators were on — suggesting that the adverse effects were reversible. Previously reported side effects of thalamic stimulation have included dysarthria (in 3 to 18 percent of patients),16,21 paresthesias (in 6 to 36 percent),14,16 dystonia (in 2 to 9 percent),14,22 balance disturbance (in 3 to 8 percent),16,36 ataxia (in 6 percent),15 and limb weakness (in 4 to 8 percent).14,19 Although these side effects are reversible in practice, many patients leave the stimulator on all the time; therefore, for many patients the benefit derived as a result of tremor control outweighs the side effects of treatment.

The surgery-related death occurred after an intracerebral hemorrhage, which may have been caused by the insertion of the test electrode, a procedure common to both thalamotomy and thalamic stimulation. The risk of intracerebral hemorrhage in stereotactic surgery is 1 to 4 percent43,44 and applies to both approaches.

For patients with bilateral tremor, we chose to compare unilateral thalamotomy with bilateral stimulation because bilateral thalamotomy is no longer used in clinical practice11,12 and because the results of bilateral stimulation should reflect the full potential of this approach. The average difference in functional gain between the thalamic-stimulation group and the thalamotomy group was similar in the patients with bilateral tremor and in those with unilateral tremor because of the effect on the analysis of the perioperative death of one patient. In patients with bilateral tremor, thalamic stimulation in the dominant hemisphere could be combined with thalamotomy in the nondominant hemisphere, but the morbidity associated with thalamotomy probably outweighs any advantage of this approach.

The long-term effect of thalamic stimulation must be evaluated further, although one center reported that its effectiveness was maintained after eight years of follow-up despite disease progression.17 A remaining question concerns the optimal location of the electrodes in view of recent reports of the effects of stimulation of the subthalamic nucleus in patients with Parkinson's disease.45-47 Stimulation of the subthalamic nucleus appears to suppress tremor adequately and to have positive effects on hypokinesia and rigidity. Levodopa-induced dyskinesias diminish as well, because the dose of medication can be reduced and, possibly, as a result of the stimulation itself.48 Subthalamic stimulation is therefore probably preferable to thalamic stimulation in patients with Parkinson's disease, although thalamic stimulation remains a therapeutic option in patients with stable Parkinson's disease in whom tremor is the dominant feature and in patients with essential tremor, for whom subthalamic stimulation has not been shown to be effective. Thalamotomy should also remain an option in the treatment of tremor in the case of well-informed patients who decide against stimulation, in economically deprived areas, or in remote areas where mandatory follow-up for adjustments of pulse generators is not possible. In patients with other causes of tremor, such as trauma, the effect of thalamic stimulation remains unknown.

Deep-brain stimulation does not restore normal brain function, and the ultimate goal is to delay or even reverse the neurodegenerative process. For the time being, thalamic stimulation is preferable to thalamotomy as a means of improving function with few adverse effects.

Funded by a grant (OG95-019) from the Dutch National Health Insurance Council.

We are indebted to A. Hovestadt, M.D., Ph.D., for assessing the severity of tremor using the videotapes of the patients, and to N.P. Quinn, M.D., Ph.D., for helpful comments on the manuscript.

Source Information

From the Departments of Neurology (P.R.S., R.M.A.B., J.D.S.), Neurosurgery (P.R.S., D.A.B.), and Clinical Epidemiology and Biostatistics (P.M.M.B., G.J.B., M.P.M.), Academic Medical Center; and the Netherlands Institute for Brain Research (E.J.W.S.) — both in Amsterdam.

Address reprint requests to Dr. Speelman at the Department of Neurology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands, or at .

References

References

  1. 1

    Jankovic J, Cardoso F, Grossman RG, Hamilton WJ. Outcome after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor. Neurosurgery 1995;37:680-686
    CrossRef | Web of Science | Medline

  2. 2

    Fox MW, Ahlskog JE, Kelly PJ. Stereotactic ventrolateralis thalamotomy for medically refractory tremor in post-levodopa era Parkinson's disease patients. J Neurosurg 1991;75:723-730
    CrossRef | Web of Science | Medline

  3. 3

    Kelly PJ, Gillingham FJ. The long-term results of stereotaxic surgery and L-dopa therapy in patients with Parkinson's disease: a 10-year follow-up study. J Neurosurg 1980;53:332-337
    CrossRef | Web of Science | Medline

  4. 4

    Lenz FA, Normand SL, Kwan HC, et al. Statistical prediction of the optimal site for thalamotomy in parkinsonian tremor. Mov Disord 1995;10:318-328
    CrossRef | Web of Science | Medline

  5. 5

    Nagaseki Y, Shibazaki T, Hirai T, et al. Long-term follow-up results of selective VIM-thalamotomy. J Neurosurg 1986;65:296-302
    CrossRef | Web of Science | Medline

  6. 6

    Wester K, Hauglie-Hanssen E. Stereotaxic thalamotomy -- experiences from the levodopa era. J Neurol Neurosurg Psychiatry 1990;53:427-430
    CrossRef | Web of Science | Medline

  7. 7

    Shahzadi S, Tasker RR, Lozano A. Thalamotomy for essential and cerebellar tremor. Stereotact Funct Neurosurg 1995;65:11-17
    CrossRef | Web of Science | Medline

  8. 8

    Goldman MS, Ahlskog JE, Kelly PJ. The symptomatic and functional outcome of stereotactic thalamotomy for medically intractable essential tremor. J Neurosurg 1992;76:924-928
    CrossRef | Web of Science | Medline

  9. 9

    Haddow LJ, Mumford C, Whittle IR. Stereotactic treatment of tremor due to multiple sclerosis. Neurosurg Q 1997;7:23-34
    Web of Science

  10. 10

    Critchley GR, Richardson PL. Vim thalamotomy for the relief of the intention tremor of multiple sclerosis. Br J Neurosurg 1998;12:559-562
    CrossRef | Web of Science | Medline

  11. 11

    Matsumoto K, Asano T, Baba T, Miyamoto T, Ohmoto T. Long-term follow-up results of bilateral thalamotomy for parkinsonism. Appl Neurophysiol 1976;39:257-260
    Medline

  12. 12

    Selby G. Stereotactic surgery for the relief of Parkinson's disease. 2. An analysis of the results in a series of 303 patients (413 operations). J Neurol Sci 1967;5:343-375
    CrossRef | Web of Science | Medline

  13. 13

    Speelman JD. Parkinson's disease and stereotaxic neurosurgery. (Ph.D. thesis. University of Amsterdam, 1991.)

  14. 14

    Koller W, Pahwa R, Busenbark K, et al. High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol 1997;42:292-299
    CrossRef | Web of Science | Medline

  15. 15

    Benabid AL, Pollak P, Gervason C, et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 1991;337:403-406
    CrossRef | Web of Science | Medline

  16. 16

    Alesch F, Pinter MM, Helscher RJ, Fertl L, Benabid AL, Koos WT. Stimulation of the ventral intermediate thalamic nucleus in tremor dominated Parkinson's disease and essential tremor. Acta Neurochir (Wien) 1995;136:75-81
    CrossRef | Web of Science | Medline

  17. 17

    Benabid AL, Pollak P, Gao DM, et al. Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J Neurosurg 1996;84:203-214
    CrossRef | Web of Science | Medline

  18. 18

    Blond S, Caparros-Lefebvre D, Parker F, et al. Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus. J Neurosurg 1992;77:62-68
    CrossRef | Web of Science | Medline

  19. 19

    Geny C, Nguyen JP, Pollin B, et al. Improvement of severe postural cerebellar tremor in multiple sclerosis by chronic thalamic stimulation. Mov Disord 1996;11:489-494
    CrossRef | Web of Science | Medline

  20. 20

    Hubble JP, Busenbark KL, Wilkinson S, Penn RD, Lyons K, Koller WC. Deep brain stimulation for essential tremor. Neurology 1996;46:1150-1153
    Web of Science | Medline

  21. 21

    Ondo W, Jankovic J, Schwartz K, Almaguer M, Simpson RK. Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson's disease tremor. Neurology 1998;51:1063-1069
    Web of Science | Medline

  22. 22

    Pollak P, Benabid AL, Gervason CL, Hoffmann D, Seigneuret E, Perret J. Long-term effects of chronic stimulation of the ventral intermediate thalamic nucleus in different types of tremor. Adv Neurol 1993;60:408-413
    Web of Science | Medline

  23. 23

    Siegfried J, Lippitz B. Chronic electrical stimulation of the VL-VPL complex and of the pallidum in the treatment of movement disorders: personal experience since 1982. Stereotact Funct Neurosurg 1994;62:71-75
    CrossRef | Web of Science | Medline

  24. 24

    Tasker RR, Munz M, Junn FS, et al. Deep brain stimulation and thalamotomy for tremor compared. Acta Neurochir Suppl (Wien) 1997;68:49-53

  25. 25

    Fahn S, Elton R. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent developments in Parkinson's disease. Vol. 2. Florham Park, N.J.: Macmillan Healthcare Information, 1987:153-64.

  26. 26

    Fahn S, Tolosa E, Marin C. Clinical rating scale for tremor. In: Jankovic J, Tolosa E, eds. Parkinson's disease and movement disorders. Munich, Germany: Urban and Schwarzenberg, 1988;225-34.

  27. 27

    Speelman JD, Van Manen J. Stereotactic thalamotomy for the relief of intention tremor of multiple sclerosis. J Neurol Neurosurg Psychiatry 1984;47:596-599
    CrossRef | Web of Science | Medline

  28. 28

    Folstein MF, Folstein SE, McHugh PR. “Mini-mental state“: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198
    CrossRef | Web of Science | Medline

  29. 29

    Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442
    Web of Science | Medline

  30. 30

    Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983;33:1444-1452
    Web of Science | Medline

  31. 31

    Schaltenbrand G, Wahren W. Atlas for stereotaxy of the human brain. Stuttgart, Germany: Georg Thieme, 1977.

  32. 32

    Tasker RR, DeCarvalho GC, Li CS, Kestle JRW. Does thalamotomy alter the course of Parkinson's disease? Adv Neurol 1996;69:563-583
    Web of Science | Medline

  33. 33

    Holbrook M, Skilbeck CE. An activities index for use with stroke patients. Age Ageing 1983;12:166-170
    CrossRef | Web of Science | Medline

  34. 34

    Schuling J, de Haan R, Limburg M, Groenier KH. The Frenchay Activities Index: assessment of functional status in stroke patients. Stroke 1993;24:1173-1177
    CrossRef | Web of Science | Medline

  35. 35

    Hariz GM, Bergenheim AT, Hariz MI, Lindberg M. Assessment of ability/disability in patients treated with chronic thalamic stimulation for tremor. Mov Disord 1998;13:78-83
    CrossRef | Web of Science | Medline

  36. 36

    Benabid AL, Pollak P, Seigneuret E, Hoffmann D, Gay E, Perret J. Chronic VIM thalamic stimulation in Parkinson's disease, essential tremor and extra-pyramidal dyskinesias. Acta Neurochir Suppl (Wien) 1993;58:39-44
    Medline

  37. 37

    Limousin P, Speelman JD, Gielen F, Janssens M. Multicentre European study of thalamic stimulation in parkinsonian and essential tremor. J Neurol Neurosurg Psychiatry 1999;66:289-296
    CrossRef | Web of Science | Medline

  38. 38

    Whittle IR, Hooper J, Pentland B. Thalamic deep-brain stimulation for movement disorders due to multiple sclerosis. Lancet 1998;351:109-110
    CrossRef | Web of Science | Medline

  39. 39

    Hooper J, Whittle IR. Long-term outcome after thalamotomy for movement disorders in multiple sclerosis. Lancet 1998;352:1984-1984
    CrossRef | Web of Science | Medline

  40. 40

    Samra K, Waltz JM, Riklan M, Koslow M, Cooper IS. Relief of intention tremor by thalamic surgery. J Neurol Neurosurg Psychiatry 1970;33:7-15
    CrossRef | Web of Science | Medline

  41. 41

    Blankensteijn JD, Lindenburg FP, Van der Graaf Y, Eikelboom BC. Influence of study design on reported mortality and morbidity rates after abdominal aortic aneurysm repair. Br J Surg 1998;85:1624-1630
    CrossRef | Web of Science | Medline

  42. 42

    Ryan RM, Fowler S, Walmsley J, Topham J. Complication data collection: a prospective, standardised, coded system for otolaryngology or other branches of surgery. Ann R Coll Surg Engl 1997;79:423-427
    Web of Science | Medline

  43. 43

    Bosch DA. Stereotactic techniques in clinical neurosurgery. Wien, Germany: Springer-Verlag, 1986.

  44. 44

    Schaltenbrand G, Walker AE. Stereotaxy of the human brain: anatomical, physiological and clinical applications. 2nd ed. Stuttgart, Germany: Georg Thieme, 1982.

  45. 45

    Kumar R, Lozano AM, Kim YJ, et al. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology 1998;51:850-855
    Web of Science | Medline

  46. 46

    Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998;339:1105-1111
    Full Text | Web of Science | Medline

  47. 47

    Rodriguez MC, Guridi OJ, Alvarez L, et al. The subthalamic nucleus and tremor in Parkinson's disease. Mov Disord 1998;13:Suppl 3:111-118
    CrossRef | Web of Science | Medline

  48. 48

    Krack P, Pollak P, Limousin P, Benazzouz A, Deuschl G, Benabid AL. From off-period dystonia to peak-dose chorea: the clinical spectrum of varying subthalamic nucleus activity. Brain 1999;122:1133-1146
    CrossRef | Web of Science | Medline

Citing Articles (234)

Citing Articles

  1. 1

    Niels Allert, Markella Markou, Anna Antonina Miskiewicz, Lars Nolden, Hans Karbe. (2011) Electrode dysfunctions in patients with deep brain stimulation: a clinical retrospective study. Acta Neurochirurgica 153:12, 2343-2349
    CrossRef

  2. 2

    Ellen L. Air, Jill L. Ostrem, Terence D. Sanger, Philip A. Starr. (2011) Deep brain stimulation in children: experience and technical pearls. Journal of Neurosurgery: Pediatrics 8:6, 566-574
    CrossRef

  3. 3

    Robin Bhatia, Arthur Dalton, Mike Richards, Chris Hopkins, Tipu Aziz, Dipankar Nandi. (2011) The incidence of deep brain stimulator hardware infection: the effect of change in antibiotic prophylaxis regimen and review of the literature. British Journal of Neurosurgery 25:5, 625-631
    CrossRef

  4. 4

    Angelo Franzini, Roberto Cordella, Giuseppe Messina, Carlo Efisio Marras, Luigi Michele Romito, Francesco Carella, Alberto Albanese, Michele Rizzi, Nardo Nardocci, Giovanna Zorzi, Edvin Zekay, Giovanni Broggi. (2011) Deep brain stimulation for movement disorders. Considerations on 276 consecutive patients. Journal of Neural Transmission 118:10, 1497-1510
    CrossRef

  5. 5

    H G E Meijer, M Krupa, H Cagnan, M A J Lourens, T Heida, H C F Martens, L J Bour, S A van Gils. (2011) From Parkinsonian thalamic activity to restoring thalamic relay using deep brain stimulation: new insights from computational modeling. Journal of Neural Engineering 8:6, 066005
    CrossRef

  6. 6

    Fabian Klostermann, Lea Krugel, Michael Wahl. (2011) Learning about language and speech from Deep Brain Stimulation. Journal of Neurolinguistics
    CrossRef

  7. 7

    Christian T Wentz, Jacob G Bernstein, Patrick Monahan, Alexander Guerra, Alex Rodriguez, Edward S Boyden. (2011) A wirelessly powered and controlled device for optical neural control of freely-behaving animals. Journal of Neural Engineering 8:4, 046021
    CrossRef

  8. 8

    Hassan Hosseini, Tomasz Mandat, Emmanuelle Waubant, Yves Agid, Catherine Lubetzki, Olivier Lyon-Caen, Bruno Stankoff, Pierre Jedynak, Pierre Cesaro, Stephane Palfi, Jean Paul Nguyen. (2011) Unilateral Thalamic Deep Brain Stimulation for Disabling Kinetic Tremor in Multiple Sclerosis.. Neurosurgery1
    CrossRef

  9. 9

    C O Oluigbo, A R Rezai. (2011) Addressing Neurological Disorders With Neuromodulation. IEEE Transactions on Biomedical Engineering 58:7, 1907-1917
    CrossRef

  10. 10

    Michael T. Barbe, Lena Liebhart, Matthias Runge, Janina Deyng, Esther Florin, Lars Wojtecki, Alfons Schnitzler, Niels Allert, Volker Sturm, Gereon R. Fink, Mohammad Maarouf, Lars Timmermann. (2011) Deep brain stimulation of the ventral intermediate nucleus in patients with essential tremor: Stimulation below intercommissural line is more efficient but equally effective as stimulation above. Experimental Neurology 230:1, 131-137
    CrossRef

  11. 11

    M. K. Lyons. (2011) Deep Brain Stimulation: Current and Future Clinical Applications. Mayo Clinic Proceedings 86:7, 662-672
    CrossRef

  12. 12

    Xiao-Ling Zhong, Jin-Tai Yu, Qun Zhang, Nai-Dong Wang, Lan Tan. (2011) Deep brain stimulation for epilepsy in clinical practice and in animal models. Brain Research Bulletin 85:3-4, 81-88
    CrossRef

  13. 13

    Lawrence M. Samkoff, Andrew D. Goodman. (2011) Symptomatic Management in Multiple Sclerosis. Neurologic Clinics 29:2, 449-463
    CrossRef

  14. 14

    Michael T. Barbe, Lena Liebhart, Matthias Runge, K. Amande M. Pauls, Lars Wojtecki, Alfons Schnitzler, Niels Allert, Gereon R. Fink, Volker Sturm, Mohammad Maarouf, Lars Timmermann. (2011) Deep brain stimulation in the nucleus ventralis intermedius in patients with essential tremor: habituation of tremor suppression. Journal of Neurology 258:3, 434-439
    CrossRef

  15. 15

    Kevin E. Novak, Arif Dalvi, Emmanuel K. Nenonene, Lawrence P. Bernstein. (2011) Surgical Treatment of Tremor. Disease-a-Month 57:3, 142-159
    CrossRef

  16. 16

    Eric Bardinet, Hayat Belaid, David Grabli, Marie-Laure Welter, Sara Fernandez Vidal, Damien Galanaud, Stéphane Derrey, Didier Dormont, Philippe Cornu, Jérôme Yelnik, Carine Karachi. (2011) Thalamic stimulation for tremor: Can target determination be improved?. Movement Disorders 26:2, 307-312
    CrossRef

  17. 17

    Young Seok Park, Jeong-Han Kang, Hae Yu Kim, Dong Wan Kang, Won Seok Chang, Joo Pyung Kim, Jin Woo Chang. (2011) A Combination Procedure with Double C-Shaped Skin Incision and Dual-Floor Burr Hole Method to Prevent Skin Erosion on the Scalp and Reduce Postoperative Skin Complications in Deep Brain Stimulation. Stereotactic and Functional Neurosurgery 89:3, 178-184
    CrossRef

  18. 18

    Stanley Fahn, Joseph Jankovic, Mark Hallett. 2011. Tremors. , 389-414.
    CrossRef

  19. 19

    Elan D. Louis. 2011. Essential tremor. , 433-448.
    CrossRef

  20. 20

    Julián Benito-León, Elan D. Louis. 2011. Management of essential tremor, including medical and surgical approaches. , 449-456.
    CrossRef

  21. 21

    Stanley Fahn, Joseph Jankovic, Mark Hallett. 2011. Surgical treatment of Parkinson disease and other movement disorders. , 157-182.
    CrossRef

  22. 22

    Yakov Gologorsky, Ron Alterman. 2011. Cerebral – Deep. , 47-72.
    CrossRef

  23. 23

    Lutz M. Weise, Gerd H. Schneider, Andreas Kupsch, Jens Haumesser, Karl T. Hoffmann. (2010) Postoperative MRI examinations in patients treated by deep brain stimulation using a non-standard protocol. Acta Neurochirurgica 152:12, 2021-2027
    CrossRef

  24. 24

    Zhen Ni, Andrew D. Pinto, Anthony E. Lang, Robert Chen. (2010) Involvement of the cerebellothalamocortical pathway in Parkinson disease. Annals of Neurology 68:6, 816-824
    CrossRef

  25. 25

    W. H. Oertel, A. Berardelli, B. R. Bloem, U. Bonuccelli, D. Burn, G. Deuschl, E. Dietrichs, G. Fabbrini, J. J. Ferreira, A. Friedman, P. Kanovsky, V. Kostic, A. Nieuwboer, P. Odin, W. Poewe, O. Rascol, C. Sampaio, M. Schüpbach, E. Tolosa, C. Trenkwalder. 2010. Late (Complicated) Parkinson's Disease. , 237-267.
    CrossRef

  26. 26

    Bruce E. Murdoch. (2010) Surgical approaches to treatment of Parkinson's disease: Implications for speech function. International Journal of Speech-Language Pathology 12:5, 375-384
    CrossRef

  27. 27

    Cristina V. Torres, Elena Moro, Adriana-Lucia Lopez-Rios, Mojgan Hodaie, Robert Chen, Adrian W. Laxton, William D. Hutchison, Jonathan O. Dostrovsky, Andres M. Lozano. (2010) Deep Brain Stimulation of the Ventral Intermediate Nucleus of the Thalamus for Tremor in Patients With Multiple Sclerosis. Neurosurgery 67:3, 646-651
    CrossRef

  28. 28

    Eliana Della Flora, Caryn L. Perera, Alun L. Cameron, Guy J. Maddern. (2010) Deep brain stimulation for essential tremor: A systematic review. Movement Disorders 25:11, 1550-1559
    CrossRef

  29. 29

    Doreen Gruber, Andrea A. Kühn, Thomas Schoenecker, Anatol Kivi, Thomas Trottenberg, Karl-Titus Hoffmann, Alireza Gharabaghi, Ute A. Kopp, Gerd-Helge Schneider, Christine Klein, Friedrich Asmus, Andreas Kupsch. (2010) Pallidal and thalamic deep brain stimulation in myoclonus-dystonia. Movement Disorders 25:11, 1733-1743
    CrossRef

  30. 30

    Jared M. Pisapia, Casey H. Halpern, Noel N. Williams, Thomas A. Wadden, Gordon H. Baltuch, Sherman C. Stein. (2010) Deep brain stimulation compared with bariatric surgery for the treatment of morbid obesity: a decision analysis study. Neurosurgical FOCUS 29:2, E15
    CrossRef

  31. 31

    Adrien Quintana, Christophe Melon, Lydia Kerkerian-Le Goff, Pascal Salin, Marc Savasta, Véronique Sgambato-Faure. (2010) Forelimb dyskinesia mediated by high-frequency stimulation of the subthalamic nucleus is linked to rapid activation of the NR2B subunit of N-methyl-d-aspartate receptors. European Journal of Neuroscience 32:3, 423-434
    CrossRef

  32. 32

    Oleksandr Popovych, Peter Tass. (2010) Synchronization control of interacting oscillatory ensembles by mixed nonlinear delayed feedback. Physical Review E 82:2,
    CrossRef

  33. 33

    Marwan I. Hariz, Patric Blomstedt, Ludvic Zrinzo. (2010) Deep brain stimulation between 1947 and 1987: the untold story. Neurosurgical FOCUS 29:2, E1
    CrossRef

  34. 34

    J. Voges, J.K. Krauss. (2010) Neurochirurgische und technische Aspekte der tiefen Hirnstimulation. Der Nervenarzt 81:6, 702-710
    CrossRef

  35. 35

    Thomas Foltynie, Marwan I Hariz. (2010) Surgical management of Parkinson’s disease. Expert Review of Neurotherapeutics 10:6, 903-914
    CrossRef

  36. 36

    L. Timmermann, J. Volkmann. (2010) Tiefe Hirnstimulation zur Behandlung von Dystonie und Tremor. Der Nervenarzt 81:6, 680-687
    CrossRef

  37. 37

    Kelly L. Collins, Emily M. Lehmann, Parag G. Patil. (2010) Deep brain stimulation for movement disorders. Neurobiology of Disease 38:3, 338-345
    CrossRef

  38. 38

    Niels Allert, Daniela Kelm, Christian Blahak, Hans-Holger Capelle, Joachim K. Krauss. (2010) Stuttering induced by thalamic deep brain stimulation for dystonia. Journal of Neural Transmission 117:5, 617-620
    CrossRef

  39. 39

    Ming-Kuei Lu, Patrick Jung, Barbara Bliem, Hsu-Tzu Shih, Yi-Ting Hseu, Yu-Wan Yang, Ulf Ziemann, Chon-Haw Tsai. (2010) The Bereitschaftspotential in essential tremor. Clinical Neurophysiology 121:4, 622-630
    CrossRef

  40. 40

    M. Kronenbuerger, S. Zobel, J. Ilgner, A. Finkelmeyer, P. Reinacher, V.A. Coenen, H. Wilms, M. Kloss, K. Kiening, C. Daniels, D. Falk, J.B. Schulz, G. Deuschl, T. Hummel. (2010) Effects of deep brain stimulation of the cerebellothalamic pathways on the sense of smell. Experimental Neurology 222:1, 144-152
    CrossRef

  41. 41

    Cordelia R. Erickson-Davis, Phyllis L. Faust, Jean-Paul G. Vonsattel, Sachin Gupta, Lawrence S. Honig, Elan D. Louis. (2010) "Hairy Baskets" Associated With Degenerative Purkinje Cell Changes in Essential Tremor. Journal of Neuropathology and Experimental Neurology 69:3, 262-271
    CrossRef

  42. 42

    Friederike Sixel-Döring, Claudia Trenkwalder, Christoph Kappus, Dieter Hellwig. (2010) Skin complications in deep brain stimulation for Parkinson’s disease: frequency, time course, and risk factors. Acta Neurochirurgica 152:2, 195-200
    CrossRef

  43. 43

    Elan D. Louis. (2010) Essential tremor as a neuropsychiatric disorder. Journal of the Neurological Sciences 289:1-2, 144-148
    CrossRef

  44. 44

    Daniel J. DiLorenzo, Joseph Jankovic, Richard K. Simpson, Hidehiro Takei, Suzanne Z. Powell. (2010) Long-term deep brain stimulation for essential tremor: 12-year clinicopathologic follow-up. Movement Disorders 25:2, 232-238
    CrossRef

  45. 45

    R. von Coelln, K. Kobayashi, J.H. Kim, W.S. Anderson, J. Winberry, F.A. Lenz. 2010. Thalamotomy. , 226-229.
    CrossRef

  46. 46

    Rahul S. Shah, Su-Youne Chang, Hoon-Ki Min, Zang-Hee Cho, Charles D. Blaha, Kendall H. Lee. (2010) Deep Brain Stimulation: Technology at the Cutting Edge. Journal of Clinical Neurology 6:4, 167
    CrossRef

  47. 47

    Kazutaka Kobayashi, Yoichi Katayama, Koichiro Sumi, Toshiharu Otaka, Toshiki Obuchi, Toshikazu Kano, Takafumi Nagaoka, Hideki Oshima, Chikashi Fukaya, Takamitsu Yamamoto, Hideki Atsumi. (2010) Effects of Electrode Implantation Angle on Thalamic Stimulation for Treatment of Tremor. Neuromodulation: Technology at the Neural Interface 13:1, 31-36
    CrossRef

  48. 48

    F. Viallet, D. Gayraud, B. Bonnefoi, L. Renie, R. Aurenty. (2010) Morbo di Parkinson idiopatico: aspetti clinici, diagnostici e terapeutici. EMC - Neurologia 10:3, 1-29
    CrossRef

  49. 49

    C Hauptmann, J-C Roulet, J J Niederhauser, W Döll, M E Kirlangic, B Lysyansky, V Krachkovskyi, M A Bhatti, U B Barnikol, L Sasse, C P Bührle, E-J Speckmann, M Götz, V Sturm, H-J Freund, U Schnell, P A Tass. (2009) External trial deep brain stimulation device for the application of desynchronizing stimulation techniques. Journal of Neural Engineering 6:6, 066003
    CrossRef

  50. 50

    Masami Nishio, Kojiro Korematsu, Susumu Yoshioka, Yasuyuki Nagai, Tomoyuki Maruo, Yukitaka Ushio, Ryuji Kaji, Satoshi Goto. (2009) Long-term suppression of tremor by deep brain stimulation of the ventral intermediate nucleus of the thalamus combined with pallidotomy in hemiparkinsonian patients. Journal of Clinical Neuroscience 16:11, 1489-1491
    CrossRef

  51. 51

    Fabian Klostermann, Michael Wahl, Jesko Schomann, Andreas Kupsch, Gabriel Curio, Frank Marzinzik. (2009) Thalamo-cortical processing of near-threshold somatosensory stimuli in humans. European Journal of Neuroscience 30:9, 1815-1822
    CrossRef

  52. 52

    Johannes Levin, Jan Mehrkens, Alexander Gerbes, Kai Bötzel. (2009) Essential tremor leading to toxic liver damage successfully treated with deep brain stimulation. Acta Neurochirurgica 151:10, 1305-1307
    CrossRef

  53. 53

    Valerie C. Anderson, Kim J. Burchiel, Melanie J. Hart, Caglar Berk, Jau-Shin Lou. (2009) A randomized comparison of thalamic stimulation and lesion on self-paced finger movement in essential tremor. Neuroscience Letters 462:2, 166-170
    CrossRef

  54. 54

    Florian Amtage, Kathrin Henschel, Björn Schelter, Jan Vesper, Jens Timmer, Carl Hermann Lücking, Bernhard Hellwig. (2009) High functional connectivity of tremor related subthalamic neurons in Parkinson’s disease. Clinical Neurophysiology 120:9, 1755-1761
    CrossRef

  55. 55

    Rodger J. Elble. (2009) Tremor: Clinical Features, Pathophysiology, and Treatment. Neurologic Clinics 27:3, 679-695
    CrossRef

  56. 56

    Benzi M. Kluger, Olga Klepitskaya, Michael S. Okun. (2009) Surgical Treatment of Movement Disorders. Neurologic Clinics 27:3, 633-677
    CrossRef

  57. 57

    Nasir Raza Awan, Andres Lozano, Clement Hamani. (2009) Deep brain stimulation: current and future perspectives. Neurosurgical FOCUS 27:1, E2
    CrossRef

  58. 58

    F. Sixel-Döring, R. Benecke, W. Fogel, R. Hilker, A. Kupsch, M. Lange, C. Schrader, L. Timmermann, J. Volkmann, G. Deuschl. (2009) Tiefe Hirnstimulation bei essenziellem Tremor. Der Nervenarzt 80:6, 662-665
    CrossRef

  59. 59

    L. Timmermann, G. Deuschl, W. Fogel, R. Hilker, A. Kupsch, M. Lange, C. Schrader, F. Sixel-Döring, J. Volkmann, R. Benecke. (2009) Tiefe Hirnstimulation bei Multiple-Sklerose-Tremor. Der Nervenarzt 80:6, 673-677
    CrossRef

  60. 60

    Juan Carlos Gómez-Esteban, Juan José Zarranz. (2009) Temblor esencial: ¿enfermedad neurodegenerativa?. Medicina Clínica 133:3, 98-99
    CrossRef

  61. 61

    R. Hilker, R. Benecke, G. Deuschl, W. Fogel, A. Kupsch, C. Schrader, F. Sixel-Döring, L. Timmermann, J. Volkmann, M. Lange. (2009) Tiefe Hirnstimulation bei idiopathischem Parkinson-Syndrom. Der Nervenarzt 80:6, 646-655
    CrossRef

  62. 62

    Krupa Pandey, Fred D. Lublin. (2009) Clinically isolated syndrome and multiple sclerosis: Rethinking the arsenal. Current Treatment Options in Neurology 11:3, 193-202
    CrossRef

  63. 63

    Dudley O’Sullivan, Malcolm Pell. (2009) Long-term follow-up of DBS of thalamus for tremor and STN for Parkinson’s disease. Brain Research Bulletin 78:2-3, 119-121
    CrossRef

  64. 64

    Michele Lanotte, Giovanni Verna, Pier Paolo Panciani, Antonio Taveggia, Maurizio Zibetti, Leonardo Lopiano, Alessandro Ducati. (2009) Management of skin erosion following deep brain stimulation. Neurosurgical Review 32:1, 111-115
    CrossRef

  65. 65

    G.-M. Hariz, P. Blomstedt, L.-O. D. Koskinen. (2008) Long-term effect of deep brain stimulation for essential tremor on activities of daily living and health-related quality of life. Acta Neurologica Scandinavica 118:6, 387-394
    CrossRef

  66. 66

    S. Kathleen Bandt, Douglas Anderson, Jose Biller. (2008) Deep brain stimulation as an effective treatment option for post–midbrain infarction-related tremor as it presents with Benedikt syndrome. Journal of Neurosurgery 109:4, 635-639
    CrossRef

  67. 67

    Julie G. Pilitsis, Leo Verhagen Metman, John R. Toleikis, Lindsay E. Hughes, Sepehr B. Sani, Roy A. E. Bakay. (2008) Factors involved in long-term efficacy of deep brain stimulation of the thalamus for essential tremor. Journal of Neurosurgery 109:4, 640-646
    CrossRef

  68. 68

    Frederik A. Pennings, P. Richard Schuurman, Pepijn van den Munckhof, Gerrit J. Bouma. (2008) Brain Tissue Oxygen Pressure Monitoring in Awake Patients during Functional Neurosurgery: The Assessment of Normal Values. Journal of Neurotrauma 25:10, 1173-1177
    CrossRef

  69. 69

    Frank Marzinzik, Michael Wahl, Gerd-Helge Schneider, Andreas Kupsch, Gabriel Curio, Fabian Klostermann. (2008) The Human Thalamus is Crucially Involved in Executive Control Operations. Journal of Cognitive Neuroscience 20:10, 1903-1914
    CrossRef

  70. 70

    V.V. Nikulin, F. Marzinzik, M. Wahl, G.-H. Schneider, A. Kupsch, G. Curio, F. Klostermann. (2008) Anticipatory activity in the human thalamus is predictive of reaction times. Neuroscience 155:4, 1275-1283
    CrossRef

  71. 71

    Michael Wahl, Frank Marzinzik, Angela D. Friederici, Anja Hahne, Andreas Kupsch, Gerd-Helge Schneider, Douglas Saddy, Gabriel Curio, Fabian Klostermann. (2008) The Human Thalamus Processes Syntactic and Semantic Language Violations. Neuron 59:5, 695-707
    CrossRef

  72. 72

    Gordon D. Chin, William D. Hutchison. (2008) Effects of cobalt and bicuculline on focal microstimulation of rat pallidal neurons in vivo. Brain Stimulation 1:3, 134-150
    CrossRef

  73. 73

    W. L. Nowinski, J. Liu, A. Thirunavuukarasuu. (2008) Quantification and visualization of three-dimensional inconsistency of the ventrointermediate nucleus of the thalamus in the Schaltenbrand-Wahren brain atlas. Acta Neurochirurgica 150:7, 647-653
    CrossRef

  74. 74

    Murray Hong, Karim Mukhida, Ivar Mendez. (2008) GDNF therapy for Parkinson’s disease. Expert Review of Neurotherapeutics 8:7, 1125-1139
    CrossRef

  75. 75

    P. Richard Schuurman, D. Andries Bosch, Maruschka P. Merkus, Johannes D. Speelman. (2008) Long-term follow-up of thalamic stimulation versus thalamotomy for tremor suppression. Movement Disorders 23:8, 1146-1153
    CrossRef

  76. 76

    Heather A. Berlin, Holly Hamilton, Eric Hollander. (2008) Experimental therapeutics for refractory obsessive-compulsive disorder: translational approaches and new somatic developments. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 75:3, 174-203
    CrossRef

  77. 77

    Seong-Min Choi, Seung-Han Lee, Man-Seok Park, Byeong-Chae Kim, Myeong-Kyu Kim, Ki-Hyun Cho. (2008) Disappearance of resting tremor after thalamic stroke involving the territory of the tuberothalamic artery. Parkinsonism & Related Disorders 14:4, 373-375
    CrossRef

  78. 78

    Kelly E. Lyons, Rajesh Pahwa. (2008) Deep brain stimulation and tremor. Neurotherapeutics 5:2, 331-338
    CrossRef

  79. 79

    Olof Sydow. (2008) Parkinson’s disease: recent development in therapies for advanced disease with a focus on deep brain stimulation (DBS) and duodenal levodopa infusion. FEBS Journal 275:7, 1370-1376
    CrossRef

  80. 80

    Karl A. Sillay, Paul S. Larson, Philip A. Starr. (2008) DEEP BRAIN STIMULATOR HARDWARE-RELATED INFECTIONS. Neurosurgery 62:2, 360-367
    CrossRef

  81. 81

    Ali R. Rezai, Andre G. Machado, Milind Deogaonkar, Hooman Azmi, Cynthia Kubu, Nicholas M. Boulis. (2008) SURGERY FOR MOVEMENT DISORDERS. Neurosurgery 62:Supplement 2, SHC-809???SHC-839
    CrossRef

  82. 82

    Elan D. Louis, Jean Paul G. Vonsattel. (2008) The emerging neuropathology of essential tremor. Movement Disorders 23:2, 174-182
    CrossRef

  83. 83

    Casey H. Halpern, Uzma Samadani, Brian Litt, Jurg L. Jaggi, Gordon H. Baltuch. (2008) Deep brain stimulation for epilepsy. Neurotherapeutics 5:1, 59-67
    CrossRef

  84. 84

    Hong Yu, Joseph S. Neimat. (2008) The treatment of movement disorders by deep brain stimulation. Neurotherapeutics 5:1, 26-36
    CrossRef

  85. 85

    Douglas Kondziolka, Joseph G. Ong, John Y. K. Lee, Robert Y. Moore, John C. Flickinger, L. Dade Lunsford. (2008) Gamma Knife thalamotomy for essential tremor. Journal of Neurosurgery 108:1, 111-117
    CrossRef

  86. 86

    N.J. Diederich, L. Verhagen Metman, R.A. Bakay, F. Alesch. (2008) Ventral Intermediate Thalamic Stimulation in Complex Tremor Syndromes. Stereotactic and Functional Neurosurgery 86:3, 167-172
    CrossRef

  87. 87

    Gammon M. Earhart, Minna Hong, Samer D. Tabbal, Joel S. Perlmutter. (2007) Effects of thalamic stimulation frequency on intention and postural tremor. Experimental Neurology 208:2, 257-263
    CrossRef

  88. 88

    Alexandre Gironell. (2007) Estrategias terapéuticas en el temblor esencial. Medicina Clínica 129:16, 632-637
    CrossRef

  89. 89

    Morten L Kringelbach, Sarah LF Owen, Tipu Z Aziz. (2007) Deep-brain stimulation. Future Neurology 2:6, 633-646
    CrossRef

  90. 90

    Ramon L. Rodriguez, Hubert H. Fernandez, Ihtsham Haq, Michael S. Okun. (2007) Pearls in Patient Selection for Deep Brain Stimulation. The Neurologist 13:5, 253-260
    CrossRef

  91. 91

    Christian Hauptmann, Oleksandr Popovych, Peter A Tass. (2007) Desynchronizing the abnormally synchronized neural activity in the subthalamic nucleus: a modeling study. Expert Review of Medical Devices 4:5, 633-650
    CrossRef

  92. 92

    Drew S. Kern, Rajeev Kumar. (2007) Deep Brain Stimulation. The Neurologist 13:5, 237-252
    CrossRef

  93. 93

    Morten L. Kringelbach, Ned Jenkinson, Sarah L.F. Owen, Tipu Z. Aziz. (2007) Translational principles of deep brain stimulation. Nature Reviews Neuroscience 8:8, 623-635
    CrossRef

  94. 94

    W. Hamel, J. Herzog, F. Kopper, M. Pinsker, D. Weinert, D. Müller, P. Krack, G. Deuschl, H. M. Mehdorn. (2007) Deep brain stimulation in the subthalamic area is more effective than nucleus ventralis intermedius stimulation for bilateral intention tremor. Acta Neurochirurgica 149:8, 749-758
    CrossRef

  95. 95

    Ali Samii, Valerie E. Kelly, Jefferson C. Slimp, Anne Shumway-Cook, Robert Goodkin. (2007) Staged unilateral versus bilateral subthalamic nucleus stimulator implantation in Parkinson disease. Movement Disorders 22:10, 1476-1481
    CrossRef

  96. 96

    Atchar Sudhyadhom, Frank J. Bova, Kelly D. Foote, Christian A. Rosado, Lindsey Kirsch-Darrow, Michael S. Okun. (2007) Limbic, associative, and motor territories within the targets for deep brain stimulation: Potential clinical implications. Current Neurology and Neuroscience Reports 7:4, 278-289
    CrossRef

  97. 97

    Pedro Emilio Bermejo Velasco. (2007) Tratamiento del temblor esencial. Medicina Clínica 129:6, 222-227
    CrossRef

  98. 98

    Julián Benito-León, Elan D Louis. (2007) Clinical update: diagnosis and treatment of essential tremor. The Lancet 369:9568, 1152-1154
    CrossRef

  99. 99

    Rianne A.J. Esselink, Rob M.A. de Bie, Rob J. de Haan, P. Richard Schuurman, Pepijn van den Munckhof, Johannes D. Speelman. (2007) A Randomized Trial Comparing Unilateral Pallidotomy with Bilateral Subthalamic Nucleus Stimulation in PD: Perspectives for Future Implication in Clinical Practice. Progress in Neurotherapeutics and Neuropsychopharmacology 2, 13
    CrossRef

  100. 100

    Fabian Klostermann, Vadim V. Nikulin, Andrea Annette Kühn, Frank Marzinzik, Michael Wahl, Alek Pogosyan, Andreas Kupsch, Gerd-Helge Schneider, Peter Brown, Gabriel Curio. (2007) Task-related differential dynamics of EEG alpha- and beta-band synchronization in cortico-basal motor structures. European Journal of Neuroscience 25:5, 1604-1615
    CrossRef

  101. 101

    Ching-Lin Hsieh, Yuh Jang, Tzu-Ying Yu, Wen-Chung Wang, Ching-Fan Sheu, Yen-Ho Wang. (2007) A Rasch Analysis of the Frenchay Activities Index in Patients With Spinal Cord Injury. Spine 32:4, 437-442
    CrossRef

  102. 102

    Casey Halpern, Howard Hurtig, Jurg Jaggi, Murray Grossman, Michelle Won, Gordon Baltuch. (2007) Deep brain stimulation in neurologic disorders. Parkinsonism & Related Disorders 13:1, 1-16
    CrossRef

  103. 103

    Marcus Koch, Jop Mostert, Dorothea Heersema, Jacques Keyser. (2007) Tremor in multiple sclerosis. Journal of Neurology 254:2, 133-145
    CrossRef

  104. 104

    Christian Blahak, Johannes C. Wöhrle, Hans-Holger Capelle, Hansjörg Bäzner, Eva Grips, Ralf Weigel, Michael G. Hennerici, Joachim K. Krauss. (2007) Tremor reduction by subthalamic nucleus stimulation and medication in advanced Parkinson’s disease. Journal of Neurology 254:2, 169-178
    CrossRef

  105. 105

    Roger J Mills, Leesien Yap, Carolyn A Young, Roger J Mills. 2007. Treatment for ataxia in multiple sclerosis. .
    CrossRef

  106. 106

    Brett J. Bordini, Ankur Garg, Catherine L. Gallagher, Brian Bell, P. Charles Garell. (2007) Neuropsychological Effects of Bilateral Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson’s Disease. Stereotactic and Functional Neurosurgery 85:2-3, 113-120
    CrossRef

  107. 107

    Takaaki Miyagishima, Akio Takahashi, Senichiro Kikuchi, Katsushige Watanabe, Masafumi Hirato, Nobuhito Saito, Yuhei Yoshimoto. (2007) Effect of Ventralis Intermedius Thalamotomy on the Area in the Sensorimotor Cortex Activated by Passive Hand Movements: fMR Imaging Study. Stereotactic and Functional Neurosurgery 85:5, 225-234
    CrossRef

  108. 108

    Peter G. Bain. (2007) Tremor. Parkinsonism & Related Disorders 13, S369-S374
    CrossRef

  109. 109

    Rodger J. Elble, . (2006) Report from a U.S. conference on essential tremor. Movement Disorders 21:12, 2052-2061
    CrossRef

  110. 110

    Julián Benito-León, Elan D Louis. (2006) Essential tremor: emerging views of a common disorder. Nature Clinical Practice Neurology 2:12, 666-678
    CrossRef

  111. 111

    M. Horstink, E. Tolosa, U. Bonuccelli, G. Deuschl, A. Friedman, P. Kanovsky, J. P. Larsen, A. Lees, W. Oertel, W. Poewe, O. Rascol, C. Sampaio. (2006) Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease. European Journal of Neurology 13:11, 1186-1202
    CrossRef

  112. 112

    Rodrigo Mercado, Tomasz Mandat, G. R. Wayne Moore, David Li, Alex MacKay, Christopher R. Honey. (2006) Three-tesla magnetic resonance imaging of the ventrolateral thalamus: a correlative anatomical description. Journal of Neurosurgery 105:2, 279-283
    CrossRef

  113. 113

    Joong-Seok Kim, Jeong-Wook Park, Woo-Jun Kim, Hee-Tae Kim, Yeong-In Kim, Kwang-Soo Lee. (2006) Disappearance of essential tremor after frontal cortical infarct. Movement Disorders 21:8, 1284-1285
    CrossRef

  114. 114

    Eus J.W. Van Someren, Myrthe D. Pticek, Johannes D. Speelman, Peter R. Schuurman, Rianne Esselink, Dick F. Swaab. (2006) New actigraph for long-term tremor recording. Movement Disorders 21:8, 1136-1143
    CrossRef

  115. 115

    G. Niepel, Ch. R. Tench, P. S. Morgan, N. Evangelou, D. P. Auer, C. S. Constantinescu. (2006) Deep gray matter and fatigue in MS. Journal of Neurology 253:7, 896-902
    CrossRef

  116. 116

    Yasin Temel, Veerle Visser-Vandewalle. (2006) Targets for deep brain stimulation in Parkinson’s disease. Expert Opinion on Therapeutic Targets 10:3, 355-362
    CrossRef

  117. 117

    Günther Deuschl, Jan Herzog, Galit Kleiner-Fisman, Cynthia Kubu, Andres M. Lozano, Kelly E. Lyons, Maria C. Rodriguez-Oroz, Filippo Tamma, Alexander I. Tröster, Jerrold L. Vitek, Jens Volkmann, Valerie Voon. (2006) Deep brain stimulation: Postoperative issues. Movement Disorders 21:S14, S219-S237
    CrossRef

  118. 118

    William S Anderson, Frederick A Lenz. (2006) Surgery Insight: deep brain stimulation for movement disorders. Nature Clinical Practice Neurology 2:6, 310-320
    CrossRef

  119. 119

    Robert E. Gross, Paul Krack, Maria C. Rodriguez-Oroz, Ali R. Rezai, Alim-Louis Benabid. (2006) Electrophysiological mapping for the implantation of deep brain stimulators for Parkinson's disease and tremor. Movement Disorders 21:S14, S259-S283
    CrossRef

  120. 120

    Rianne AJ Esselink, Rob MA de Bie, P Richard Schuurman, D Andries Bosch, Johannes D Speelman. (2006) Parkinson’s disease and deep brain stimulation. Aging Health 2:3, 473-487
    CrossRef

  121. 121

    Lisa Skipper, Jian-Jun Liu, Eng-King Tan. (2006) Polymorphisms in candidate genes: implications for the current treatment of Parkinson’s disease. Expert Opinion on Pharmacotherapy 7:7, 849-855
    CrossRef

  122. 122

    William G. Ondo. (2006) Essential tremor: Treatment options. Current Treatment Options in Neurology 8:3, 256-267
    CrossRef

  123. 123

    R. B. Govindan, Jan Raethjen, Kathrin Arning, Florian Kopper, Günther Deuschl. (2006) Time Delay and Partial Coherence Analyses to Identify Cortical Connectivities. Biological Cybernetics 94:4, 262-275
    CrossRef

  124. 124

    Wery P. M. van den Wildenberg, Geert J. M. van Boxtel, Maurits W. van der Molen, D. Andries Bosch, Johannes D. Speelman, Cornelis H. M. Brunia. (2006) Stimulation of the Subthalamic Region Facilitates the Selection and Inhibition of Motor Responses in Parkinson's Disease. Journal of Cognitive Neuroscience 18:4, 626-636
    CrossRef

  125. 125

    Ritsuko Hanajima, Jonathan O. Dostrovsky, Andres M. Lozano, Robert Chen. (2006) Dissociation of thalamic high frequency oscillations and slow component of sensory evoked potentials following damage to ascending pathways. Clinical Neurophysiology 117:4, 906-911
    CrossRef

  126. 126

    Patric Blomstedt, Marwan I. Hariz. (2006) Are Complications Less Common in Deep Brain Stimulation than in Ablative Procedures for Movement Disorders?. Stereotactic and Functional Neurosurgery 84:2-3, 72-81
    CrossRef

  127. 127

    Gin S Malhi, Colleen Loo, Catherine M Cahill, Jim Lagopoulos, Philip Mitchell, Perminder Sachdev. (2006) "Getting physical": the management of neuropsychiatric disorders using novel physical treatments. Neuropsychiatric Disease and Treatment 2:2, 165-179
    CrossRef

  128. 128

    Matthew O. Hebb, Paula Gaudet, Ivar Mendez. (2006) Deep brain stimulation to treat hyperkinetic symptoms of cockayne syndrome. Movement Disorders 21:1, 112-115
    CrossRef

  129. 129

    Frances Weaver, Kenneth Follett, Kwan Hur, Dolores Ippolito, Matthew Stern. (2005) Deep brain stimulation in Parkinson disease: a metaanalysis of patient outcomes. Journal of Neurosurgery 103:6, 956-967
    CrossRef

  130. 130

    Serge Pinto, Michèle Gentil, Paul Krack, Paul Sauleau, Valérie Fraix, Alim-Louis Benabid, Pierre Pollak. (2005) Changes induced by levodopa and subthalamic nucleus stimulation on parkinsonian speech. Movement Disorders 20:11, 1507-1515
    CrossRef

  131. 131

    P. Blomstedt, M. I. Hariz. (2005) Hardware-related complications of deep brain stimulation: a ten year experience. Acta Neurochirurgica 147:10, 1061-1064
    CrossRef

  132. 132

    John Y. K. Lee, Douglas Kondziolka. (2005) Thalamic deep brain stimulation for management of essential tremor. Journal of Neurosurgery 103:3, 400-403
    CrossRef

  133. 133

    Kendall H. Lee, Frederick L. Hitti, Mark H. Shalinsky, Uhnoh Kim, James C. Leiter, David W. Roberts. (2005) Abolition of spindle oscillations and 3-Hz absence seizurelike activity in the thalamus by using high-frequency stimulation: potential mechanism of action. Journal of Neurosurgery 103:3, 538-545
    CrossRef

  134. 134

    Fred Rincon, Elan D Louis. (2005) Benefits and risks of pharmacological and surgical treatments for essential tremor: disease mechanisms and current management. Expert Opinion on Drug Safety 4:5, 899-913
    CrossRef

  135. 135

    Alexander I. Tröster, Rajesh Pahwa, Julie A. Fields, Caroline M. Tanner, Kelly E. Lyons. (2005) Quality of life in Essential Tremor Questionnaire (QUEST): Development and initial validation. Parkinsonism & Related Disorders 11:6, 367-373
    CrossRef

  136. 136

    Stephane Thobois, Stephen Tisch, Jing Xie-Brustolin, Patrick Mertens, Marwan I. Hariz, Isabelle Benatru, Emmanuel Broussolle, Patricia Limousin-Dowsey. (2005) Can chronic subthalamic nucleus stimulation induce de novo tremor in Parkinson's disease?. Movement Disorders 20:8, 1066-1069
    CrossRef

  137. 137

    Warren M Grill. (2005) Safety considerations for deep brain stimulation: review and analysis. Expert Review of Medical Devices 2:4, 409-420
    CrossRef

  138. 138

    Stéphane Thobois, Florence Delamarre-Damier, Pascal Derkinderen. (2005) Treatment of motor dysfunction in Parkinson's disease: an overview. Clinical Neurology and Neurosurgery 107:4, 269-281
    CrossRef

  139. 139

    Ali Samii, Jefferson C. Slimp, Robert Goodkin. (2005) Unilateral subthalamic nucleus deep brain stimulation contralateral to thalamic stimulation in Parkinson disease. Parkinsonism & Related Disorders 11:4, 257-258
    CrossRef

  140. 140

    Leo Verhagen Metman, Shaun T. O'Leary. (2005) Role of surgery in the treatment of motor complications. Movement Disorders 20:S11, S45-S56
    CrossRef

  141. 141

    Kenou van Rijckevorsel, Basel Abu Serieh, Marianne de Tourtchaninoff, Christian Raftopoulos. (2005) Deep EEG Recordings of the Mammillary Body in Epilepsy Patients. Epilepsia 46:5, 781-785
    CrossRef

  142. 142

    Alessandra Gorgulho, Antonio A. F. De Salles, Leonardo Frighetto, Eric Behnke. (2005) Incidence of hemorrhage associated with electrophysiological studies performed using macroelectrodes and microelectrodes in functional neurosurgery. Journal of Neurosurgery 102:5, 888-896
    CrossRef

  143. 143

    Elan D Louis. (2005) Essential tremor. The Lancet Neurology 4:2, 100-110
    CrossRef

  144. 144

    Daniel Tarsy, Lisa Scollins, Kristin Corapi, Siobhan O’Herron, Diana Apetauerova, Thorkild Norregaard. (2005) Progression of Parkinson’s Disease following Thalamic Deep Brain Stimulation for Tremor. Stereotactic and Functional Neurosurgery 83:5-6, 222-227
    CrossRef

  145. 145

    Mwiza Ushe, Jonathan W. Mink, Fredy J. Revilla, Angie Wernle, Patricia Schneider Gibson, Lori McGee-Minnich, Minna Hong, Keith M. Rich, Kelly E. Lyons, Rajesh Pahwa, Joel S. Perlmutter. (2004) Effect of stimulation frequency on tremor suppression in essential tremor. Movement Disorders 19:10, 1163-1168
    CrossRef

  146. 146

    Sorin Breit, Jrg B. Schulz, Alim-Louis Benabid. (2004) Deep brain stimulation. Cell and Tissue Research 318:1, 275-288
    CrossRef

  147. 147

    Kelly L. Sullivan, Robert A. Hauser, Theresa A. Zesiewicz. (2004) Essential Tremor. The Neurologist 10:5, 250-258
    CrossRef

  148. 148

    Rajesh Pahwa, Kelly E. Lyons. (2004) Options in the treatment of motor fluctuations and dyskinesias in Parkinson's disease: a brief review. Neurologic Clinics 22:3, S35-S52
    CrossRef

  149. 149

    Takamitsu Yamamoto, Yoichi Katayama, Toshikazu Kano, Kazutaka Kobayashi, Hideki Oshima, Chikashi Fukaya. (2004) Deep brain stimulation for the treatment of parkinsonian, essential, and poststroke tremor: a suitable stimulation method and changes in effective stimulation intensity. Journal of Neurosurgery 101:2, 201-209
    CrossRef

  150. 150

    Puneet Plaha, Nikunj K. Patel, Steven S. Gill. (2004) Stimulation of the subthalamic region for essential tremor. Journal of Neurosurgery 101:1, 48-54
    CrossRef

  151. 151

    Paul T. Martinelli, Keith E. Schulze, Bruce R. Nelson. (2004) Mohs Micrographic Surgery in a Patient with a Deep Brain Stimulator: A Review of the Literature on Implantable Electrical Devices. Dermatologic Surgery 30:7, 1021-1030
    CrossRef

  152. 152

    Mitsuhiro Ogura, Naoyuki Nakao, Ekini Nakai, Yuji Uematsu, Toru Itakura. (2004) The mechanism and effect of chronic electrical stimulation of the globus pallidus for treatment of Parkinson disease. Journal of Neurosurgery 100:6, 997-1001
    CrossRef

  153. 153

    Warren M. Grill, Andrea N. Snyder, Svjetlana Miocinovic. (2004) Deep brain stimulation creates an informational lesion of the stimulated nucleus. NeuroReport 15:7, 1137-1140
    CrossRef

  154. 154

    Robert E Gross. (2004) Deep brain stimulation in the treatment of neurological and psychiatric disease. Expert Review of Neurotherapeutics 4:3, 465-478
    CrossRef

  155. 155

    Efstathios Papavassiliou, Geoff Rau, Susan Heath, Aviva Abosch, Nicholas M. Barbaro, Paul S. Larson, Kathleen Lamborn, Philip A. Starr. (2004) Thalamic Deep Brain Stimulation for Essential Tremor: Relation of Lead Location to Outcome. Neurosurgery 54:5, 1120-1130
    CrossRef

  156. 156

    Ali Samii, John G Nutt, Bruce R Ransom. (2004) Parkinson's disease. The Lancet 363:9423, 1783-1793
    CrossRef

  157. 157

    Andres M. Lozano, Neil Mahant. (2004) Deep brain stimulation surgery for Parkinson's disease: mechanisms and consequences. Parkinsonism & Related Disorders 10, S49-S57
    CrossRef

  158. 158

    Michael S. Okun, Jerrold L. Vitek. (2004) Lesion therapy for Parkinson's disease and other movement disorders: Update and controversies. Movement Disorders 19:4, 375-389
    CrossRef

  159. 159

    Jason M. Schwalb, Andres M. Lozano. (2004) Surgical Management of Tremor. Neurosurgery Quarterly 14:1, 60-68
    CrossRef

  160. 160

    Patricia Limousin-Dowsey. (2004) Thalamic stimulation in essential tremor. The Lancet Neurology 3:2, 80
    CrossRef

  161. 161

    Brian Harris Kopell, Benjamin Greenberg, Ali R. Rezai. (2004) Deep Brain Stimulation for Psychiatric Disorders. Journal of Clinical Neurophysiology 21:1, 51-67
    CrossRef

  162. 162

    Gavin Giovannoni. (2004) Management of Secondary-Progressive Multiple Sclerosis. CNS Drugs 18:10, 653-669
    CrossRef

  163. 163

    Alim Louis Benabid. (2003) Deep brain stimulation for Parkinson’s disease. Current Opinion in Neurobiology 13:6, 696-706
    CrossRef

  164. 164

    V Sturm. (2003) The nucleus accumbens: a target for deep brain stimulation in obsessive–compulsive- and anxiety-disorders. Journal of Chemical Neuroanatomy 26:4, 293-299
    CrossRef

  165. 165

    Zelma H.T. Kiss, Marshall Wilkinson, Jerry Krcek, Oksana Suchowersky, Bin. Hu, William F. Murphy, Doug Hobson, Ron R. Tasker. (2003) Is the target for thalamic deep brain stimulation the same as for thalamotomy?. Movement Disorders 18:10, 1169-1175
    CrossRef

  166. 166

    Christopher M. Duma. (2003) Movement Disorder Radiosurgery. Techniques in Neurosurgery 9:3, 181-190
    CrossRef

  167. 167

    Bruce P. Hollingsworth, Anthony H. Harris. (2003) The economic consequences of introducing deep brain stimulation for the treatment of advanced Parkinson's disease in Australia. Australasian Journal on Ageing 22:3, 127-130
    CrossRef

  168. 168

    Jack J. Chen, David M. Swope. (2003) Essential Tremor: Diagnosis and Treatment. Pharmacotherapy 23:9, 1105-1122
    CrossRef

  169. 169

    Marwan I. Hariz. (2003) From functional neurosurgery to ?interventional? neurology: Survey of publications on thalamotomy, pallidotomy, and deep brain stimulation for Parkinson's disease from 1966 to 2001. Movement Disorders 18:8, 845-853
    CrossRef

  170. 170

    Simone Betchen, Michael Kaplitt. (2003) Current Opinion in Neurology 16:4, 487-493
    CrossRef

  171. 171

    Sylvie Raoul, Mirella Faighel, Isabelle Rivier, Marc Vrin, Youenn Lajat, Philippe Damier. (2003) Staged lesions through implanted deep brain stimulating electrodes: A new surgical procedure for treating tremor or dyskinesias. Movement Disorders 18:8, 933-938
    CrossRef

  172. 172

    B Hellwig, B Schelter, B Guschlbauer, J Timmer, C.H Lücking. (2003) Dynamic synchronisation of central oscillators in essential tremor. Clinical Neurophysiology 114:8, 1462-1467
    CrossRef

  173. 173

    Simone A. Betchen, Michael Kaplitt. (2003) Future and current surgical therapies in Parkinsonʼs disease. Current Opinion in Neurology 16:4, 487-493
    CrossRef

  174. 174

    Elizabeth Hawkins-Walsh. (2003) Case Study of a Young Man With Tremor. Journal of the American Academy of Nurse Practitioners 15:5, 220-223
    CrossRef

  175. 175

    Atsushi Umemura, Jurg L. Jaggi, Howard I. Hurtig, Andrew D. Siderowf, Amy Colcher, Matthew B. Stern, Gordon H. Baltuch. (2003) Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients. Journal of Neurosurgery 98:4, 779-784
    CrossRef

  176. 176

    Uzma Samadani, Atsushi Umemura, Jurg L. Jaggi, Amy Colcher, Eric L. Zager, Gordon H. Baltuch. (2003) Thalamic deep brain stimulation for disabling tremor after excision of a midbrain cavernous angioma. Journal of Neurosurgery 98:4, 888-890
    CrossRef

  177. 177

    Helen Bronte-Stewart. (2003) Parkinson’s disease: Surgical options. Current Treatment Options in Neurology 5:2, 131-147
    CrossRef

  178. 178

    L. Gabriels, P. Cosyns, B. Nuttin, H. Demeulemeester, J. Gybels. (2003) Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: psychopathological and neuropsychological outcome in three cases. Acta Psychiatrica Scandinavica 107:4, 275-282
    CrossRef

  179. 179

    Paul C. Francel, David Coffman, Paul Tompkins. (2003) Lesional and Deep Brain Stimulator Surgery for Essential Tremor and Other Movement Disorders. Techniques in Neurosurgery 9:1, 9-22
    CrossRef

  180. 180

    Richard K. Simpson,. (2003) Neurosurgical Management of Unusual Movement Disorders. Techniques in Neurosurgery 9:1, 32-37
    CrossRef

  181. 181

    B Haslinger, H Boecker, C Büchel, J Vesper, V.M Tronnier, R Pfister, F Alesch, J.R Moringlane, J.K Krauss, B Conrad, M Schwaiger, A.O Ceballos-Baumann. (2003) Differential modulation of subcortical target and cortex during deep brain stimulation. NeuroImage 18:2, 517-524
    CrossRef

  182. 182

    Stig Rehncrona, Bo Johnels, Hkan Widner, Anna-Lena Trnqvist, Marwan Hariz, Olof Sydow. (2003) Long-term efficacy of thalamic deep brain stimulation for tremor: Double-blind assessments. Movement Disorders 18:2, 163-170
    CrossRef

  183. 183

    Walter Pirker, Claude Back, Willibald Gerschlager, Franco Laccone, Francois Alesch. (2003) Chronic thalamic stimulation in a patient with spinocerebellar ataxia type 2. Movement Disorders 18:2, 222-225
    CrossRef

  184. 184

    Kelly E Lyons, Rajesh Pahwa, Cynthia L Comella, Mahmood S Eisa, Rodger J Elble, Stanley Fahn, Joseph Jankovic, Jorge L Juncos, William C Koller, William G Ondo, Kapil D Sethi, Matthew B Stern, Caroline M Tanner, Ron Tintner, Ray L Watts. (2003) Benefits and Risks of Pharmacological Treatments for Essential Tremor. Drug Safety 26:7, 461-481
    CrossRef

  185. 185

    Drew S. Kern, Rajeev Kumar. 2003. Surgical Treatment of Parkinson's Disease. , 757-762.
    CrossRef

  186. 186

    John H. Noseworthy. (2003) Treatment of Multiple Sclerosis and Related Disorders: What's New in the Past 2 Years?. Clinical Neuropharmacology 26:1, 28-37
    CrossRef

  187. 187

    Iman Feiz-Erfan, Patrick Han, Andrew G. Shetter, Robert F. Spetzler. 2003. Thalamotomy. , 500-501.
    CrossRef

  188. 188

    Sam P. Javedan, Andrew G. Shetter. 2003. Deep Brain Stimulation. , 824-825.
    CrossRef

  189. 189

    Elan D Louis, Dikoma C Shungu, Steven Chan, Xiangling Mao, Eva C Jurewicz, Dryden Watner. (2002) Metabolic abnormality in the cerebellum in patients with essential tremor: a proton magnetic resonance spectroscopic imaging study. Neuroscience Letters 333:1, 17-20
    CrossRef

  190. 190

    C. W. Olanow. (2002) Surgical therapy for Parkinson's disease. European Journal of Neurology 9:s3, 31-39
    CrossRef

  191. 191

    Caglar Berk, Jason Carr, Marci Sinden, Jeff Martzke, Christopher R. Honey. (2002) Thalamic deep brain stimulation for the treatment of tremor due to multiple sclerosis: a prospective study of tremor and quality of life. Journal of Neurosurgery 97:4, 815-820
    CrossRef

  192. 192

    Peter Tass. (2002) Effective desynchronization with bipolar double-pulse stimulation. Physical Review E 66:3,
    CrossRef

  193. 193

    Ron Tintner, Joseph Jankovic. (2002) Treatment options for Parkinsonʼs disease. Current Opinion in Neurology 15:4, 467-476
    CrossRef

  194. 194

    Rodger J. Elble. (2002) Essential tremor is a monosymptomatic disorder. Movement Disorders 17:4, 633-637
    CrossRef

  195. 195

    Theresa A. Zesiewicz, Elmyra Encarnacion, Robert A. Hauser. (2002) Management of essential tremor. Current Neurology and Neuroscience Reports 2:4, 324-330
    CrossRef

  196. 196

    Alan J. Thompson. (2002) Progress in neurorehabilitation in multiple sclerosis. Current Opinion in Neurology 15:3, 267-270
    CrossRef

  197. 197

    (2002) Deep Brain Stimulation. Journal of Neurosurgery 96:6,
    CrossRef

  198. 198

    Michael Y. Oh, Aviva Abosch, Seong H. Kim, Anthony E. Lang, Andres M. Lozano. (2002) Long-term Hardware-related Complications of Deep Brain Stimulation. Neurosurgery 50:6, 1268-1276
    CrossRef

  199. 199

    Olivier Rascol, Christopher Goetz, William Koller, Werner Poewe, Cristina Sampaio. (2002) Treatment interventions for Parkinson's disease: an evidence based assessment. The Lancet 359:9317, 1589-1598
    CrossRef

  200. 200

    Jan Kassubek, Freimut D. Juengling, Bernhard Hellwig, Joachim Spreer, Carl H. Lücking. (2002) Thalamic gray matter changes in unilateral Parkinsonian resting tremor: a voxel-based morphometric analysis of 3-dimensional magnetic resonance imaging. Neuroscience Letters 323:1, 29-32
    CrossRef

  201. 201

    Gnther Deuschl, Peter Bain. (2002) Deep brain stimulation for trauma: Patient selection and evaluation. Movement Disorders 17:S3, S102-S111
    CrossRef

  202. 202

    Gnther Deuschl, Hagai Bergman. (2002) Pathophysiology of nonparkinsonian tremors. Movement Disorders 17:S3, S41-S48
    CrossRef

  203. 203

    Johannes D. Speelman, Richard Schuurman, Rob M.A. de Bie, Rianne A.J. Esselink, D. Andries Bosch. (2002) Stereotactic neurosurgery for tremor. Movement Disorders 17:S3, S84-S88
    CrossRef

  204. 204

    Caglar Berk, Christopher R. Honey. (2002) Bilateral thalamic deep brain stimulation for the treatment of head tremor. Journal of Neurosurgery 96:3, 615-618
    CrossRef

  205. 205

    Paul Krack, Jonathan Dostrovsky, Igor Ilinsky, Kristy Kultas-Ilinsky, Fred Lenz, Andres Lozano, Jerry Vitek. (2002) Surgery of the motor thalamus: Problems with the present nomenclatures. Movement Disorders 17:S3, S2-S8
    CrossRef

  206. 206

    J.D. Speelman, D.A. Bosch. (2002) Neurosurgical treatment modalities in Parkinson's disease. Movement Disorders 17:S2, S83-S85
    CrossRef

  207. 207

    William Ondo, Kevin Dat Vuong, Michael Almaguer, Joseph Jankovic, Richard K. Simpson. (2001) Thalamic deep brain stimulation: Effects on the nontarget limbs. Movement Disorders 16:6, 1137-1142
    CrossRef

  208. 208

    The Deep-Brain Stimulation for Parkinson's Disease Study Group. (2001) Deep-Brain Stimulation of the Subthalamic Nucleus or the Pars Interna of the Globus Pallidus in Parkinson's Disease. New England Journal of Medicine 345:13, 956-963
    Full Text

  209. 209

    Louis, Elan D., . (2001) Essential Tremor. New England Journal of Medicine 345:12, 887-891
    Full Text

  210. 210

    Paul Krack, Laurent Vercueil. (2001) Review of the functional surgical treatment of dystonia. European Journal of Neurology 8:5, 389-399
    CrossRef

  211. 211

    Elan D. Louis. (2001) Etiology of essential tremor: Should we be searching for environmental causes?. Movement Disorders 16:5, 822-829
    CrossRef

  212. 212

    Michael Y. Oh, Mojgan Hodaie, Seong Ho Kim, Ahmed Alkhani, Anthony E. Lang, Andres M. Lozano. (2001) Deep Brain Stimulator Electrodes Used for Lesioning: Proof of Principle. Neurosurgery 49:2, 363-369
    CrossRef

  213. 213

    J. Eric Ahlskog. (2001) Parkinson's disease: medical and surgical treatment. Neurologic Clinics 19:3, 579-605
    CrossRef

  214. 214

    John Hammerstad, Penelope Hogarth. (2001) Parkinson’s disease: Surgical options. Current Neurology and Neuroscience Reports 1:4, 313-319
    CrossRef

  215. 215

    Thomas Trottenberg, Wassilios Meissner, Guy Arnold, Karl-Max Einhaupl, Andreas Kupsch, Christian Kabus, Thomas Funk. (2001) Neurostimulation of the ventral intermediate thalamic nucleus in inherited myoclonus-dystonia Syndrome. Movement Disorders 16:4, 769-771
    CrossRef

  216. 216

    A.M. Lozano. (2001) Deep brain stimulation for Parkinson's disease. Parkinsonism & Related Disorders 7:3, 199-203
    CrossRef

  217. 217

    Brian Litt, Gordon Baltuch. (2001) Brain Stimulation for Epilepsy. Epilepsy & Behavior 2:3, S61-S67
    CrossRef

  218. 218

    Jason M. Schwalb, Howard A. Riina, Brett Skolnick, Jurg L. Jaggi, Tanya Simuni, Gordon H. Baltuch. (2001) Revision of deep brain stimulator for tremor. Journal of Neurosurgery 94:6, 1010-1012
    CrossRef

  219. 219

    Elan D. Louis, Blair Ford, Steven Frucht, Livia F. Barnes, Ming X-Tang, Ruth Ottman. (2001) Risk of tremor and impairment from tremor in relatives of patients with essential tremor: A community-based family study. Annals of Neurology 49:6, 761-769
    CrossRef

  220. 220

    Daniel Tarsy. (2001) Deep Brain Stimulation and Movement Disorders. Epilepsy & Behavior 2:3, S45-S54
    CrossRef

  221. 221

    W Meissner. (2001) Striatal dopaminergic metabolism is increased by deep brain stimulation of the subthalamic nucleus in 6-hydroxydopamine lesioned rats. Neuroscience Letters 303:3, 165-168
    CrossRef

  222. 222

    William C. Koller, Kelly E. Lyons, Steven B. Wilkinson, Alexander I. Troster, Rajesh Pahwa. (2001) Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor. Movement Disorders 16:3, 464-468
    CrossRef

  223. 223

    Margaret J. Kovach, Jimmy Ruiz, Katerina Kimonis, Sajjad Mueed, Shobhit Sinha, Connie Higgins, Suzanne Elble, Rodger Elble, Virginia E. Kimonis. (2001) Genetic heterogeneity in autosomal dominant essential tremor. Genetics in Medicine 3:3, 197-199
    CrossRef

  224. 224

    Joachim K. Krauss, Richard K. Simpson, William G. Ondo, Thomas Pohle, Jean-Marc Burgunder, Joseph Jankovic. (2001) Concepts and Methods in Chronic Thalamic Stimulation for Treatment of Tremor: Technique and Application. Neurosurgery 48:3, 535-543
    CrossRef

  225. 225

    Michael J. Aminoff. (2001) Parkinson's disease. Neurologic Clinics 19:1, 119-128
    CrossRef

  226. 226

    Alois A. Obwegeser, Ryan J. Uitti, Robert J. Witte, John A. Lucas, Margaret F. Turk, Robert E. Wharen. (2001) Quantitative and Qualitative Outcome Measures after Thalamic Deep Brain Stimulation to Treat Disabling Tremors. Neurosurgery 48:2, 274-284
    CrossRef

  227. 227

    B Hellwig, S Häußler, B Schelter, M Lauk, B Guschlbauer, J Timmer, CH Lücking. (2001) Tremor-correlated cortical activity in essential tremor. The Lancet 357:9255, 519-523
    CrossRef

  228. 228

    Rajesh Pahwa, Kelly E. Lyons, Steven B. Wilkinson, Alexander I. Trster, John Overman, Jennifer Kieltyka, William C. Koller. (2001) Comparison of thalamotomy to deep brain stimulation of the thalamus in essential tremor. Movement Disorders 16:1, 140-143
    CrossRef

  229. 229

    W Meissner. (2000) The influence of pallidal deep brain stimulation on striatal dopaminergic metabolism in the rat. Neuroscience Letters 296:2-3, 149-152
    CrossRef

  230. 230

    K. VAN LAERE, C. VAN DER LINDEN, P. SANTENS, V. VANDEWALLE, J. CAEMAERT, P. L. IR, D. VAN DEN ABBEELE, R. DIERCKX. (2000) 99Tcm-ECD SPET perfusion changes by internal pallidum stimulation in Parkinson??s disease. Nuclear Medicine Communications 21:12, 1103-1112
    CrossRef

  231. 231

    Günther Deuschl, Roland Wenzelburger, Jan Raethjen. (2000) Tremor. Current Opinion in Neurology 13:4, 437-443
    CrossRef

  232. 232

    A Lozano. (2000) Vim Thalamic Stimulation for Tremor. Archives of Medical Research 31:3, 266-269
    CrossRef

  233. 233

    Mark Hallet, Irene Litvan, . (2000) Scientific position paper of the Movement Disorder Society evaluation of surgery for Parkinson's disease. Movement Disorders 15:3, 436-438
    CrossRef

  234. 234

    Deuschl, Günther, . (2000) New Treatment Options for Tremors. New England Journal of Medicine 342:7, 505-507
    Full Text